Maren Leifheit-Nestler
Overview
Explore the profile of Maren Leifheit-Nestler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
1144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lahring J, Leifheit-Nestler M, Ewert A, Herzig N, Koppl C, Pott V, et al.
J Clin Endocrinol Metab
. 2024 Jul;
110(2):e218-e230.
PMID: 39049782
Context: The pathophysiology of cystinosis-associated metabolic bone disease is complex. Objective: We hypothesized a disturbed interaction between osteoblasts and osteoclasts. Methods: This binational cross-sectional multicenter study included 103 patients with...
2.
Tietze H, Pott V, Kanzelmeyer N, Memaran N, Baumann U, Mindermann C, et al.
Osteoporos Int
. 2023 Nov;
35(3):533-542.
PMID: 37940696
Purpose: Soluble receptor activator of nuclear factor kappa B ligand (sRANKL) and osteoprotegerin (OPG) are regulators of osteoclast differentiation and activation and thus bone metabolic turnover in children. Adequate pediatric...
3.
Pott V, Tietze H, Kanzelmeyer N, von der Born J, Baumann U, Mindermann C, et al.
J Clin Endocrinol Metab
. 2023 Oct;
109(3):668-679.
PMID: 37850343
Context: The assessment of phosphate homeostasis in children is challenging due to the marked changes in laboratory parameters during growth and development, and the lack of adequate reference values. Objective:...
4.
Feger M, Alber J, Strotmann J, Grund A, Leifheit-Nestler M, Haffner D, et al.
Acta Physiol (Oxf)
. 2023 Sep;
239(4):e14049.
PMID: 37746883
Aims: Phosphate and vitamin D homeostasis are controlled by fibroblast growth factor 23 (FGF23) from bone suppressing renal phosphate transport and enhancing 24-hydroxylase (Cyp24a1), thereby inactivating 1,25(OH) D . Serum...
5.
Ewert A, Rehberg M, Schlingmann K, Hiort O, John-Kroegel U, Metzing O, et al.
J Clin Endocrinol Metab
. 2023 Apr;
108(10):e998-e1006.
PMID: 37097907
Context: Burosumab has been approved for the treatment of children and adults with X-linked hypophosphatemia (XLH). Real-world data and evidence for its efficacy in adolescents are lacking. Objective: To assess...
6.
Bacchetta J, Peter Schmitt C, Bakkaloglu S, Cleghorn S, Leifheit-Nestler M, Prytula A, et al.
Pediatr Nephrol
. 2023 Feb;
38(9):3163-3181.
PMID: 36786859
Background: Infants with chronic kidney disease (CKD) form a vulnerable population who are highly prone to mineral and bone disorders (MBD) including biochemical abnormalities, growth retardation, bone deformities, and fractures....
7.
Richter B, Kapanadze T, Weingartner N, Walter S, Vogt I, Grund A, et al.
FASEB J
. 2022 Jun;
36(7):e22407.
PMID: 35713543
Dietary phosphate intake in the Western population greatly exceeds the recommended dietary allowance and is linked to enhanced cardiovascular and all-cause mortality. It is unclear whether a chronic high phosphate...
8.
Haffner D, Leifheit-Nestler M, Grund A, Schnabel D
Pediatr Nephrol
. 2022 Mar;
37(10):2289-2302.
PMID: 35352187
Here, we discuss the management of different forms of rickets, including new therapeutic approaches based on recent guidelines. Management includes close monitoring of growth, the degree of leg bowing, bone...
9.
Leifheit-Nestler M, Vogt I, Haffner D, Richter B
Adv Exp Med Biol
. 2022 Mar;
1362:107-134.
PMID: 35288877
Phosphate is essential for proper cell function by providing the fundamentals for DNA, cellular structure, signaling and energy production. The homeostasis of phosphate is regulated by the phosphaturic hormones fibroblast...
10.
Printza N, Dotis J, Sinha M, Leifheit-Nestler M
Front Pediatr
. 2022 Mar;
10:856656.
PMID: 35252071
No abstract available.